Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions (original) (raw)

• Wolpin, B.M. & Mayer, R.J. Systemic treatment of colorectal cancer. Gastroenterology 134, 1296–1310 (2008).
  Article CAS PubMed Google Scholar
• Markowitz, S.D. & Bertagnolli, M.M. Molecular origins of cancer: Molecular basis of colorectal cancer. N. Engl. J. Med. 361, 2449–2460 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Verhaak, R.G. et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17, 98–110 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Barretina, J. et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603–607 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Julien, S. et al. Characterization of a large panel of patient-derived tumor xenografts representing the clinical heterogeneity of human colorectal cancer. Clin. Cancer Res. 18, 5314–5328 (2012).
  Article CAS PubMed Google Scholar
• Uronis, J.M. et al. Histological and molecular evaluation of patient-derived colorectal cancer explants. PLoS ONE 7, e38422 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Calon, A. et al. Dependency of colorectal cancer on a TGF-β–driven program in stromal cells for metastasis initiation. Cancer Cell 22, 571–584 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Pagès, F. et al. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. J. Clin. Oncol. 27, 5944–5951 (2009).
  Article CAS PubMed Google Scholar
• Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330–337 (2012).
• Shen, L. et al. Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc. Natl. Acad. Sci. USA 104, 18654–18659 (2007).
  Article PubMed PubMed Central Google Scholar
• Schlicker, A. et al. Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines. BMC Med. Genomics 5, 66 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Sugai, T. et al. Analysis of molecular alterations in left- and right-sided colorectal carcinomas reveals distinct pathways of carcinogenesis: proposal for new molecular profile of colorectal carcinomas. J. Mol. Diagn. 8, 193–201 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Lascorz, J., Chen, B., Hemminki, K. & Forsti, A. Consensus pathways implicated in prognosis of colorectal cancer identified through systematic enrichment analysis of gene expression profiling studies. PLoS ONE 6, e18867 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Salazar, R. et al. Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer. J. Clin. Oncol. 29, 17–24 (2011).
  Article PubMed Google Scholar
• Popovici, V. et al. Identification of a poor-prognosis BRAF-mutant-like population of patients with colon cancer. J. Clin. Oncol. 30, 1288–1295 (2012).
  Article CAS PubMed Google Scholar
• Gray, R.G. et al. Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer. J. Clin. Oncol. 29, 4611–4619 (2011).
  Article PubMed Google Scholar
• Tibshirani, R., Hastie, T., Narasimhan, B. & Chu, G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc. Natl. Acad. Sci. USA 99, 6567–6572 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Khambata-Ford, S. et al. Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab. J. Clin. Oncol. 25, 3230–3237 (2007).
  Article CAS PubMed Google Scholar
• Boparai, K.S. et al. A serrated colorectal cancer pathway predominates over the classic WNT pathway in patients with hyperplastic polyposis syndrome. Am. J. Pathol. 178, 2700–2707 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Kambara, T. et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 53, 1137–1144 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Van der Flier, L.G. et al. The intestinal Wnt/TCF signature. Gastroenterology 132, 628–632 (2007).
  Article CAS PubMed Google Scholar
• Taube, J.H. et al. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc. Natl. Acad. Sci. USA 107, 15449–15454 (2010).
  Article PubMed PubMed Central Google Scholar
• Curran, S. et al. Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers. Clin. Cancer Res. 10, 8229–8234 (2004).
  Article CAS PubMed Google Scholar
• Shioiri, M. et al. Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Br. J. Cancer 94, 1816–1822 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Spaderna, S. et al. A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology 131, 830–840 (2006).
  Article CAS PubMed Google Scholar
• de Sousa E Melo, F. et al. Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patients. Cell Stem Cell 9, 476–485 (2011).
  Article CAS PubMed Google Scholar
• Bruna, A. et al. TGFbeta induces the formation of tumour-initiating cells in claudinlow breast cancer. Nat. Commun. 3, 1055 (2012).
  Article CAS PubMed Google Scholar
• Bennecke, M. et al. Ink4a/Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis. Cancer Cell 18, 135–146 (2010).
  Article CAS PubMed Google Scholar
• Leystra, A.A. et al. Mice expressing activated PI3K rapidly develop advanced colon cancer. Cancer Res. 72, 2931–2936 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Merlos-Suárez, A. et al. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 8, 511–524 (2011).
  PubMed Google Scholar
• Jorissen, R.N. et al. DNA copy-number alterations underlie gene expression differences between microsatellite stable and unstable colorectal cancers. Clin. Cancer Res. 14, 8061–8069 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Tsuji, S. et al. Potential responders to FOLFOX therapy for colorectal cancer by Random Forests analysis. Br. J. Cancer 106, 126–132 (2012).
  Article CAS PubMed Google Scholar
• Wagner, K.W. et al. Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. Nat. Med. 13, 1070–1077 (2007).
  Article CAS PubMed Google Scholar
• McCall, M.N., Bolstad, B.M. & Irizarry, R.A. Frozen robust multiarray analysis (fRMA). Biostatistics 11, 242–253 (2010).
  Article PubMed PubMed Central Google Scholar
• McCall, M.N., Uppal, K., Jaffee, H.A., Zilliox, M.J. & Irizarry, R.A. The Gene Expression Barcode: leveraging public data repositories to begin cataloging the human and murine transcriptomes. Nucleic Acids Res. 39, D1011–D1015 (2011).
  Article CAS PubMed Google Scholar
• Monti, S., Tamayo, P., Mesirov, J. & Golub, T. Consensus clustering: A resampling-based method for class discovery and visualization of gene expression microarray data. Mach. Learn. 52, 91–118 (2003).
  Article Google Scholar
• Tibshirani, R., Walther, G. & Hastie, T. Estimating the number of clusters in a data set via the gap statistic. J. R. Stat. Soc. Series B Stat. Methodol. 63, 411–423 (2001).
  Article Google Scholar
• Rousseeuw, P.J. Silhouettes: a graphical aid to the interpretation and validation of cluster analysis. J. Comput. Appl. Math. 20, 53–65 (1987).
  Article Google Scholar
• Tusher, V.G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98, 5116–5121 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Tibshirani, R., Hastie, T., Narasimhan, B. & Chu, G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc. Natl. Acad. Sci. USA 99, 6567–6572 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Johnson, W.E., Li, C. & Rabinovic, A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118–127 (2007).
  Article PubMed Google Scholar
• Clark-Langone, K.M., Sangli, C., Krishnakumar, J. & Watson, D. Translating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX Colon Cancer Assay. BMC Cancer 10, 691 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Breiman, L. Random forests. Mach. Learn. 45, 5–32 (2001).
  Article Google Scholar
• Ruifrok, A.C. & Johnston, D.A. Quantification of histochemical staining by color deconvolution. Anal. Quant. Cytol. Histol. 23, 291–299 (2001).
  CAS PubMed Google Scholar
• Otsu, N. A threshold selection method from gray-level histograms. IEEE Trans. Syst. Man Cybern. 9, 62–66 (1979).
  Article Google Scholar
• Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545–15550 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Weisenberger, D.J. et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat. Genet. 38, 787–793 (2006).
  Article CAS PubMed Google Scholar